The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
// STATE LEGISLATION TRACKER

Kentucky HB 896: AN ACT relating to hemp products and declaring an emergency.

โš–๏ธ NEUTRAL for peptide users ๐Ÿ‘ค LOW user impact ๐Ÿ“œ Status: Introduced
State
Kentucky
Bill
HB 896
Session
2026RS
Filed
2026-03-04
Read the bill
OpenStates โ†’
Last reviewed
2026-11-02

Plain-English Summary

Kentucky HB896 is an act relating to hemp products and declaring an emergency. It defines terms, establishes laboratory and testing standards, and sets procedures for the sale and transportation of hemp-derived cannabinoid products and cannabis-infused beverages. The bill also adjusts licensing fees for cannabis-infused beverages.

Key Points

  • New definitions and testing standards for hemp products.
  • Procedures for sale and transport of hemp-derived products.
  • Adjusted licensing fees for cannabis-infused beverages.
  • Potential impact on the broader cannabinoid market.

What to Watch For

i
Note Clarification on how "hemp products" are defined and regulated under KRS Chapter 217.
i
Note Impact of new laboratory and testing standards on product availability and cost.
i
Note Changes in licensing fees for cannabis-infused beverages and their effect on businesses.

Where the Bill Stands

The bill was introduced and referred to the Licensing, Occupations, & Administrative Regulations committee in the House.
ยท Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.
Bill page generated 2026-11-04 ยท enriched via codex gpt-5.5
Source: OpenStates v3 API ยท View official bill ยท โ† back to all laws